Laurie P. Havanec - 12 Feb 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief People Officer
Signature
/s/ Laurie P. Havanec
Issuer symbol
CVS
Transactions as of
12 Feb 2024
Transactions value $
$0
Form type
4
Filing time
14 Feb 2024, 17:14:41 UTC
Previous filing
12 May 2023
Next filing
28 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +16.8K +82.49% $0.00 37.2K 12 Feb 2024 Direct F1
holding CVS Common Stock (Restricted) 14.7K 12 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 27.6K 12 Feb 2024 Common Stock 27.6K $74.30 Direct F2
holding CVS Stock Option 21.8K 12 Feb 2024 Common Stock 21.8K $101.09 Direct F3
holding CVS Stock Option 52K 12 Feb 2024 Common Stock 52K $74.31 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
F2 Option became exercisable in four equal installments, commencing 4/1/2022.
F3 Option became exercisable in four equal installments, commencing 4/1/2023.
F4 Option becomes exercisable in four equal installments, commencing 4/1/2024.